A synthetic opioid derived from the kratom plant sold in gummies, tablets, and drink mixes is slated to be restricted because of concerns that it has a serious potential for abuse.
The compound is called 7-hydroxymitragynine, commonly known as 7-OH. It occurs naturally in trace amounts in kratom. Products containing 7-OH have potentially dangerous, enhanced levels and are not approved by the Food and Drug Administration (FDA).
